克罗恩病与痛风的关系：双样本孟德尔随机化研究
Causal Association between Crohn’s Disease and Gout: A 2-Sample Mendelian Randomization Study
DOI: 10.12677/acm.2024.1482221, PDF,   
作者: 张 婧, 徐丽丽, 刘昱昭, 黄雅静, 孙存卫, 王颜刚*：青岛大学附属医院内分泌科，山东 青岛；孙 祯：青岛大学附属医院神经内科，山东 青岛
关键词: 克罗恩病；痛风；炎症性肠病；孟德尔随机化；Crohn’s Disease； Gout； Inflammatory Bowel Disease； Mendelian Randomization
摘要: 目的：克罗恩病和痛风发病率逐年增高，但其关联性尚未明确。本研究利用孟德尔随机化方法，探讨克罗恩病与痛风之间的潜在因果关系。方法：我们选取与克罗恩病和痛风显著关联的单核苷酸多态性作为工具变量，利用公开的全基因组关联研究的汇总统计数据进行分析。我们采用多种MR方法并进行了敏感性分析。结果：克罗恩病与痛风的发病风险正相关(OR = 1.00060493，95%置信区间1.00013013~1.00107996，P值 = 0.01251316)。敏感性分析进一步印证了该发现，未见明显的异质性和水平多效性。结论：我们的研究结果表明克罗恩病与痛风之间存在正相关关系。这一发现为克罗恩病与痛风之间的关系及其病理生理机制提供了新的见解，并为痛风的预防和治疗提出了新策略。
Abstract: Objective: The incidence of Crohn’s disease and gout is increasing year by year, but the correlation is not clear, so we conducted a two-sample bidirectional mendelian randomization study to examine the association between them. Method: We selected single nucleotide polymorphisms significantly associated with Crohn’s disease and gout as instrumental variables and analyzed them using summary statistics from publicly available genome-wide association studies. We used multiple MR methods and performed sensitivity analyses. Results: The results revealed that Crohn’s disease was positively associated with the risk of developing gout (Odds Ratio, OR = 1.00060493, 95% Confidence Interval, CI, 1.00013013~1.00107996, P value = 0.01251316). Sensitivity analyses further corroborated the finding, with no significant heterogeneity or horizontal pleiotropy seen. Conclusions: Our findings suggest a positive association between Crohn’s disease and gout. This finding provides new insights into the relationship between Crohn’s disease and gout and its pathophysiologic mechanisms, and new strategies for the prevention and treatment of gout.
文章引用：张婧, 孙祯, 徐丽丽, 刘昱昭, 黄雅静, 孙存卫, 王颜刚. 克罗恩病与痛风的关系：双样本孟德尔随机化研究[J]. 临床医学进展, 2024, 14(8): 339-348. https://doi.org/10.12677/acm.2024.1482221

参考文献

[1] 倪青. 高尿酸血症和痛风病证结合诊疗指南(2021-01-20) [J]. 世界中医药, 2021, 16(2): 183-189.
[2] Kyu, H.H., Abate, D., Abate, K.H., Abay, S.M., Abbafati, C., Abbasi, N., et al. (2018) Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 359 Diseases and Injuries and Healthy Life Expectancy (HALE) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1859-1922. [Google Scholar] [CrossRef] [PubMed]
[3] Danve, A. and Neogi, T. (2020) Rising Global Burden of Gout: Time to Act. Arthritis & Rheumatology, 72, 1786-1788. [Google Scholar] [CrossRef] [PubMed]
[4] Song, J., Jin, C., Shan, Z., Teng, W. and Li, J. (2022) Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-Sectional Survey from 31 Provinces in Mainland of China. Journal of Translational Internal Medicine, 10, 134-145. [Google Scholar] [CrossRef] [PubMed]
[5] Gao, Q., Cheng, X., Merriman, T.R., Wang, C., Cui, L., Zhang, H., et al. (2021) Trends in the Manifestations of 9754 Gout Patients in a Chinese Clinical Center: A 10-Year Observational Study. Joint Bone Spine, 88, Article ID: 105078. [Google Scholar] [CrossRef] [PubMed]
[6] Zhu, B., Wang, Y., Zhou, W., Jin, S., Shen, Z., Zhang, H., et al. (2022) Trend Dynamics of Gout Prevalence among the Chinese Population, 1990-2019: A Joinpoint and Age-Period-Cohort Analysis. Frontiers in Public Health, 10, Article 1008598. [Google Scholar] [CrossRef] [PubMed]
[7] Torres, J., Mehandru, S., Colombel, J. and Peyrin-Biroulet, L. (2017) Crohn’s Disease. The Lancet, 389, 1741-1755. [Google Scholar] [CrossRef] [PubMed]
[8] Rogler, G., Singh, A., Kavanaugh, A. and Rubin, D.T. (2021) Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology, 161, 1118-1132. [Google Scholar] [CrossRef] [PubMed]
[9] Burgess, S., Scott, R.A., Timpson, N.J., Davey Smith, G. and Thompson, S.G. (2015) Using Published Data in Mendelian Randomization: A Blueprint for Efficient Identification of Causal Risk Factors. European Journal of Epidemiology, 30, 543-552. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, Y., Yan, S., Li, X., Huang, Q., Luo, L., Wang, Y., et al. (2022) Causal Association between Periodontitis and Type 2 Diabetes: A Bidirectional Two-Sample Mendelian Randomization Analysis. Frontiers in Genetics, 12, Article 792396. [Google Scholar] [CrossRef] [PubMed]
[11] Boef, A.G.C., Dekkers, O.M. and le Cessie, S. (2015) Mendelian Randomization Studies: A Review of the Approaches Used and the Quality of Reporting. International Journal of Epidemiology, 44, 496-511. [Google Scholar] [CrossRef] [PubMed]
[12] Davies, N.M., Holmes, M.V. and Davey Smith, G. (2018) Reading Mendelian Randomisation Studies: A Guide, Glossary, and Checklist for Clinicians. BMJ, 362, k601. [Google Scholar] [CrossRef] [PubMed]
[13] Verbanck, M., Chen, C., Neale, B. and Do, R. (2018) Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred from Mendelian Randomization between Complex Traits and Diseases. Nature Genetics, 50, 693-698. [Google Scholar] [CrossRef] [PubMed]
[14] Luo, J., Xu, Z., Noordam, R., van Heemst, D. and Li-Gao, R. (2021) Depression and Inflammatory Bowel Disease: A Bidirectional Two-Sample Mendelian Randomization Study. Journal of Crohn’s and Colitis, 16, 633-642. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, Y., Liu, Z., Choudhury, T., Cornelis, M.C. and Liu, W. (2020) Habitual Coffee Intake and Risk for Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study. European Journal of Nutrition, 60, 1761-1767. [Google Scholar] [CrossRef] [PubMed]
[16] Bowden, J., Davey Smith, G. and Burgess, S. (2015) Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through Egger Regression. International Journal of Epidemiology, 44, 512-525. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, X., Kong, J., Diao, X., Cai, J., Zheng, J., Xie, W., et al. (2020) Depression and Prostate Cancer Risk: A Mendelian Randomization Study. Cancer Medicine, 9, 9160-9167. [Google Scholar] [CrossRef] [PubMed]
[18] Yao, X., Zhang, C., Xing, Y., Xue, G., Zhang, Q., Pan, F., et al. (2017) Remodelling of the Gut Microbiota by Hyperactive NLRP3 Induces Regulatory T Cells to Maintain Homeostasis. Nature Communications, 8, Article No. 1896. [Google Scholar] [CrossRef] [PubMed]
[19] Neudecker, V., Haneklaus, M., Jensen, O., Khailova, L., Masterson, J.C., Tye, H., et al. (2017) Myeloid-derived Mir-223 Regulates Intestinal Inflammation via Repression of the NLRP3 Inflammasome. Journal of Experimental Medicine, 214, 1737-1752. [Google Scholar] [CrossRef] [PubMed]
[20] Mao, L., Kitani, A., Similuk, M., Oler, A.J., Albenberg, L., Kelsen, J., et al. (2018) Loss-of-Function CARD8 Mutation Causes NLRP3 Inflammasome Activation and Crohn’s Disease. Journal of Clinical Investigation, 128, 1793-1806. [Google Scholar] [CrossRef] [PubMed]
[21] Wan, X., Xu, C., Lin, Y., Lu, C., Li, D., Sang, J., et al. (2016) Uric Acid Regulates Hepatic Steatosis and Insulin Resistance through the NLRP3 Inflammasome-Dependent Mechanism. Journal of Hepatology, 64, 925-932. [Google Scholar] [CrossRef] [PubMed]
[22] Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., et al. (2015) NLRP3 Inflammasome: From a Danger Signal Sensor to a Regulatory Node of Oxidative Stress and Inflammatory Diseases. Redox Biology, 4, 296-307. [Google Scholar] [CrossRef] [PubMed]
[23] Yin, W., Zhou, Q., OuYang, S., Chen, Y., Gong, Y. and Liang, Y. (2019) Uric Acid Regulates NLRP3/IL-1β Signaling Pathway and Further Induces Vascular Endothelial Cells Injury in Early CKD through ROS Activation and K+ Efflux. BMC Nephrology, 20, Article No. 319. [Google Scholar] [CrossRef] [PubMed]
[24] Wark, G., Samocha-Bonet, D., Ghaly, S. and Danta, M. (2020) The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review. Nutrients, 13, Article 135. [Google Scholar] [CrossRef] [PubMed]
[25] Wang, J., Chen, Y., Zhong, H., Chen, F., Regenstein, J., Hu, X., et al. (2021) The Gut Microbiota as a Target to Control Hyperuricemia Pathogenesis: Potential Mechanisms and Therapeutic Strategies. Critical Reviews in Food Science and Nutrition, 62, 3979-3989. [Google Scholar] [CrossRef] [PubMed]
[26] Sivaprakasam, S., Prasad, P.D. and Singh, N. (2016) Benefits of Short-Chain Fatty Acids and Their Receptors in Inflammation and Carcinogenesis. Pharmacology & Therapeutics, 164, 144-151. [Google Scholar] [CrossRef] [PubMed]
[27] Hou, T., Dai, H., Wang, Q., Hou, Y., Zhang, X., Lin, H., et al. (2023) Dissecting the Causal Effect between Gut Microbiota, DHA, and Urate Metabolism: A Large-Scale Bidirectional Mendelian Randomization. Frontiers in Immunology, 14, Article 1148591. [Google Scholar] [CrossRef] [PubMed]
[28] Herbert, J., Teeter, E., Burstiner, L.S., Doka, R., Royer, A., Owings, A.H., et al. (2022) Urinary Manifestations in African American and Caucasian Inflammatory Bowel Disease Patients: A Retrospective Cohort Study. BMC Urology, 22, Article No. 1. [Google Scholar] [CrossRef] [PubMed]
[29] Fagagnini, S., Heinrich, H., Rossel, J., Biedermann, L., Frei, P., Zeitz, J., et al. (2017) Risk Factors for Gallstones and Kidney Stones in a Cohort of Patients with Inflammatory Bowel Diseases. PLOS ONE, 12, e0185193. [Google Scholar] [CrossRef] [PubMed]

为你推荐